Multilevel System Intervention Based on Information Platform to Reduce Ischemic Stroke Recurrence Rate
NCT ID: NCT05852080
Last Updated: 2023-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-05-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving In-hospital Stroke Service Utilisation in China
NCT03317639
Computer Scan Based Analysing System on Improving Stroke Management Quality Evaluation
NCT03684629
Cohort Study for Severe Ischaemic Stroke
NCT03222024
Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation
NCT04487340
Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke
NCT04135872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention arm
Hospitals in the intervention arm will receive a multilevel system intervention based on information platform
multilevel system intervention based on information platform
1. Standardized templates of medical record
2. Continuous medical quality control and feedback system: the hospital included in the study upload the medical records of all AIS patients by medical records scanning system. Quality control platform of Cerebral apoplexy in Zhejiang province extracts and analyze the data through the computer and calculates the percentage of stroke of undetermined cause.
3. Team collaboration based on video conferencing: hospitals will receive corresponding suggestions for their improvement from experts online.
4. Enhanced feedback incentives
control arm
Hospitals in the control arm will receive no intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
multilevel system intervention based on information platform
1. Standardized templates of medical record
2. Continuous medical quality control and feedback system: the hospital included in the study upload the medical records of all AIS patients by medical records scanning system. Quality control platform of Cerebral apoplexy in Zhejiang province extracts and analyze the data through the computer and calculates the percentage of stroke of undetermined cause.
3. Team collaboration based on video conferencing: hospitals will receive corresponding suggestions for their improvement from experts online.
4. Enhanced feedback incentives
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients admitted with neurological deficit consistent with ischemic stroke within 7 days of of symptoms onset. (\*Symptom onset is defined by the "last seen normal" principle)
* Confirmation of new ischemic stroke by objective modality of CT scan and MRI (had relevant lesions on DWI).
* Informed consent from patient or legally authorised representative (primarily spouse, parents, adult children, otherwise indicated).
Exclusion Criteria
* Patients who losing his medical record of having the incomplete medical record
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zexin Chen
Role: PRINCIPAL_INVESTIGATOR
Tthe second affiliated hospital, school of medicine, Zhejiang University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Min Lou
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MISA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.